rs35219531

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_001377540.1(SLMAP):​c.1968T>A​(p.Leu656Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0254 in 1,613,962 control chromosomes in the GnomAD database, including 677 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.016 ( 31 hom., cov: 32)
Exomes 𝑓: 0.026 ( 646 hom. )

Consequence

SLMAP
NM_001377540.1 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.277

Publications

4 publications found
Variant links:
Genes affected
SLMAP (HGNC:16643): (sarcolemma associated protein) This gene encodes a component of a conserved striatin-interacting phosphatase and kinase complex. Striatin family complexes participate in a variety of cellular processes including signaling, cell cycle control, cell migration, Golgi assembly, and apoptosis. The protein encoded by this gene is a coiled-coil, tail-anchored membrane protein with a single C-terminal transmembrane domain that is posttranslationally inserted into membranes. Mutations in this gene are associated with Brugada syndrome, a cardiac channelopathy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2015]
SLMAP Gene-Disease associations (from GenCC):
  • Brugada syndrome
    Inheritance: Unknown, AD Classification: SUPPORTIVE, LIMITED, NO_KNOWN Submitted by: Genomics England PanelApp, Orphanet, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.5).
BP6
Variant 3-57912649-T-A is Benign according to our data. Variant chr3-57912649-T-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 240722.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.277 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0161 (2449/152298) while in subpopulation NFE AF = 0.0286 (1948/68018). AF 95% confidence interval is 0.0276. There are 31 homozygotes in GnomAd4. There are 1092 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 2449 Unknown,AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLMAPNM_001377540.1 linkc.1968T>A p.Leu656Leu synonymous_variant Exon 20 of 25 ENST00000671191.1 NP_001364469.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLMAPENST00000671191.1 linkc.1968T>A p.Leu656Leu synonymous_variant Exon 20 of 25 NM_001377540.1 ENSP00000499458.1 A0A590UJK3

Frequencies

GnomAD3 genomes
AF:
0.0161
AC:
2449
AN:
152180
Hom.:
31
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00500
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00910
Gnomad ASJ
AF:
0.00202
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00393
Gnomad FIN
AF:
0.00923
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0286
Gnomad OTH
AF:
0.0139
GnomAD2 exomes
AF:
0.0164
AC:
4115
AN:
250368
AF XY:
0.0168
show subpopulations
Gnomad AFR exome
AF:
0.00408
Gnomad AMR exome
AF:
0.00634
Gnomad ASJ exome
AF:
0.00428
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0110
Gnomad NFE exome
AF:
0.0291
Gnomad OTH exome
AF:
0.0136
GnomAD4 exome
AF:
0.0264
AC:
38609
AN:
1461664
Hom.:
646
Cov.:
31
AF XY:
0.0256
AC XY:
18634
AN XY:
727162
show subpopulations
African (AFR)
AF:
0.00358
AC:
120
AN:
33480
American (AMR)
AF:
0.00651
AC:
291
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00390
AC:
102
AN:
26136
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39694
South Asian (SAS)
AF:
0.00562
AC:
485
AN:
86254
European-Finnish (FIN)
AF:
0.0103
AC:
548
AN:
53312
Middle Eastern (MID)
AF:
0.00191
AC:
11
AN:
5768
European-Non Finnish (NFE)
AF:
0.0321
AC:
35747
AN:
1111906
Other (OTH)
AF:
0.0216
AC:
1304
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
1896
3792
5687
7583
9479
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1322
2644
3966
5288
6610
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0161
AC:
2449
AN:
152298
Hom.:
31
Cov.:
32
AF XY:
0.0147
AC XY:
1092
AN XY:
74466
show subpopulations
African (AFR)
AF:
0.00498
AC:
207
AN:
41556
American (AMR)
AF:
0.00908
AC:
139
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00202
AC:
7
AN:
3468
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5194
South Asian (SAS)
AF:
0.00394
AC:
19
AN:
4826
European-Finnish (FIN)
AF:
0.00923
AC:
98
AN:
10616
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0286
AC:
1948
AN:
68018
Other (OTH)
AF:
0.0137
AC:
29
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
121
242
362
483
604
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
34
68
102
136
170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0220
Hom.:
23
Bravo
AF:
0.0158
Asia WGS
AF:
0.00231
AC:
8
AN:
3478
EpiCase
AF:
0.0257
EpiControl
AF:
0.0289

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Sep 08, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
May 28, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Brugada syndrome Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.50
CADD
Benign
5.7
DANN
Benign
0.74
PhyloP100
-0.28
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35219531; hg19: chr3-57898376; COSMIC: COSV55854724; COSMIC: COSV55854724; API